Whilst the literature may be consistent in reporting that leptin is found in higher concentrations in those patients with EC versus non-cancer controls, this does not appear to be independent of BMI after all, suggesting that leptin may not be a useful standalone diagnostic biomarker. The gene discussed is LEP; the disease is cancer.